Watch Best Movie Trailers of 2009
BioXcel Corporation: India‚ an increasingly important role in the Life Science Business
BioXcel Corporation: India, an inc...
From:iTunes
17:26
Mercury Therapeutics: Novel Approaches in the Treatment of Type 2 Diabetes
Mercury Therapeutics: Novel Approac...
From:iTunes
11:16
Pfizer‚ Roche and CoNCERT Pharmaceuticals discuss the out-licensing practices of large pharma
Pfizer, Roche and CoNCERT Pharmace...
From:iTunes
41:41
Pfizer and Wyeth’s $68bn Deal
Pfizer and Wyeth’s $68bn Deal
From:iTunes
06:17
PharmaTelevision: The Story So Far
PharmaTelevision: The Story So Far
From:iTunes
12:26
The Pharmaceutical Outlook for 2007 - An EU Perspective
The Pharmaceutical Outlook for 2007...
From:iTunes
28:07
PharmaDeals Research: Outsourcing of Deal Making Analysis
PharmaDeals Research: Outsourcing o...
From:iTunes
05:13
Oxford Technology Management: Delivering Success from Seed Capital Investment
Oxford Technology Management: Deliv...
From:iTunes
17:43

More Videos Like PharmaVentures Business Review-Simcere Pharmaceuticals: Dr...

 Feed

COMMENT

COMMENT

SHARE

SHARE

SAVE

SAVE

RATE

RATE

EMBED

EMBED

Share or Comment on this Video

Comment on this Video

Share this Video

Save this Video

Rate this Video

Embed this Video

Recent Comments
Add a Comment
Add your Own Comment

By adding a comment, you agree to the AOL ® Video Portal - Guidelines & Safety Tips | Text Comments Help

Clear
Add
    ADVERTISEMENT
    Now Playing
    PharmaVentures Business Review-Simcere Pharmaceuticals: Dr H Ming Pang, He...
    Description
    Dr Pang talks to Fintan Walton about biotechnology trends in China. He examines what the Chinese pharmaceutical and biotechnology industry has to offer the global market, discusses the opportunities in China and presents his thoughts on the challenges that this region faces. The discussion provides an in-depth analysis and informative overview of this emergent territory, which has lately been the subject of much attention.
    Dr Pang talks to Fintan Walton about biotechnology trends in China. He examines what the Chinese pha... More
    Channel:iTunes
    Distributor:PharmaVentures Ltd
    Tags:Investing, PharmaVentures...More
    Rating:
    Disclaimer

    This Video is provided and hosted from a third party server. AOL is not responsible for any activities originating with such third party server.

    View Disclaimer

    More From iTunes

    January 1‚ 2010: Look Ahead 2010
    January 1, 2010: Look Ahead 2010
    We ask several prominent relig...
    Category:Religious
    03:35
    Smalltalk Daily 12/30/09: Encrypting Your Settings
    Smalltalk Daily 12/30/09: Encrypting Your Settings
    How to encrypt the settings fi...
    Category:Technology
    03:25
    The 700 Club: December 30‚ 2009
    The 700 Club: December 30, 2009
    A state trooper forgives the m...
    Category:Religious
    Picture Your Dreams & Goals #4
    Picture Your Dreams & Goals #4
    What will your life look like ...
    Category:Religious
    Picture Your Dreams & Goals #5
    Picture Your Dreams & Goals #5
    What will your life look like ...
    Category:Religious
    ABC World News‚ 12.30.09
    ABC World News, 12.30.09
    Airline Security; Seals Disape...
    Category:News
    Pregnant Robot Trains Students
    Pregnant Robot Trains Students
    Presenting our most popular vi...
    Category:News
    04:51
    The CNN Daily
    The CNN Daily
    The daily news podcast of reco...
    Category:News
    02:56
    See All Related Items
    AOL Video
    Send Feedback
    AOL Sports
    AOL Video in other countries:
    Dr Pang talks to Fintan Walton about biotechnology trends in China. He examines what the Chinese pharmaceutical and biotechnology industry has to offer the global market, discusses the opportunities in China and presents his thoughts on the challenges that this region faces. The discussion provides an in-depth analysis and informative overview of ...
    © 2009 AOL Inc. All Rights Reserved.
    Notify AOL
    Notify AOL of Inappropriate Content.

    Use this area to report a violation of Community Standards.

    Please review errors below and try again.

    Complete E-mail Address

    Reason:

    Additional Description (Not required) Max:300 characters